GLP-1 drugs' heart health benefits not solely from weight loss: study
GLP-1 drugs' heart health benefits not solely from weight loss: study
Medical
 Oct 29 2025    02:10 AM
 
 
Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a person loses while taking the GLP-1 medication, a new study finds.   Read More
Tags
Leave a comment
Comments ({{ storyCommentsCount }})
{{comment.name}}
{{comment.created | tsdate:'MMMM dd, yyyy'}}
{{comment.created | tsdate:'h:mm a'}}
{{comment.comment}}
{{replyComments.name}}
{{replyComments.created | tsdate:'MMMM dd, yyyy'}}
{{replyComments.created | tsdate:'h:mm a'}}
{{replyComments.comment }}

Related